000 01347 a2200361 4500
005 20250515182116.0
264 0 _c20110418
008 201104s 0 0 eng d
022 _a1476-5454
024 7 _a10.1038/eye.2009.189
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWright, A D
245 0 0 _aDiabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.
_h[electronic resource]
260 _bEye (London, England)
_cJan 2010
300 _a1-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xtherapeutic use
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aBenzimidazoles
_xtherapeutic use
650 0 4 _aBiphenyl Compounds
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aDiabetic Retinopathy
_xepidemiology
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aLisinopril
_xtherapeutic use
650 0 4 _aTetrazoles
_xtherapeutic use
700 1 _aDodson, P M
773 0 _tEye (London, England)
_gvol. 24
_gno. 1
_gp. 1-6
856 4 0 _uhttps://doi.org/10.1038/eye.2009.189
_zAvailable from publisher's website
999 _c19056138
_d19056138